Zocdoc wants to make every provider bookable everywhere patients search
A new network expansion connects providers to AI platforms, insurance directories, and search engines through a single integration
AI built for $0 and a spreadsheet is fixing medicine shortages in Sierra Leone
A Wharton and Penn Engineering collaboration with Sierra Leone's government shows how low-cost machine learning can solve one of global health's most persistent logistics problems
Surgeon.AI wants to give every trainee surgeon the educational support that geography usually denies...
Professor Shafi Ahmed's new AI platform pairs a personalised learning companion with a career tracking index built specifically for surgical education
GE HealthCare’s new AI tool gives hospitals a 72-hour warning before capacity breaks down
CareIntellect for Operations predicts bottlenecks before they cascade, and two major academic medical centers are first to test it
AI reads the ‘geography’ of pancreatic tumors to predict who’s most likely to relapse
Mayo Clinic researchers show that how residual cancer is arranged in tissue, not just how much remains, may sharpen recurrence risk estimates after surgery
Verily Health pulls in NVIDIA and CU Healthcare Innovation Fund in extended fundraising round
The precision health AI company adds a major chip maker to its investor list as it scales its data platform and patient engagement tools
HealthEx connects personal health records to Meta’s Muse AI agent
A new integration lets Americans bring their actual medical history into AI-assisted health conversations, with consent controls built in from the start
Huawei and partners launch four AI healthcare scenarios at HIMSS26 APAC
From smart wards to clinical decision support, the tech giant is moving AI out of the pilot phase and into hospital workflows across Asia-Pacific
Weave Bio and Takeda cut IND drafting time by 97% in AI regulatory trial
A new collaboration between the two companies shows measurable speed gains in submission preparation, with human oversight kept firmly in place
GSK moves its mRNA flu vaccine into late-stage trials after promising mid-stage results
A dual-protein approach sets GSK's candidate apart from Moderna's recently approved shot, and the race to redefine flu vaccination is now very much on